Efficacy of a Right-sided Ablation of the Anterior Ganglionated Plexus for Neurally Mediated Syncope
RecruitingNCT04755101Phase: NAStarted 2021-03-24
Summary
The third study on CardNM (CardNMH3 study) is a multicenter, double-blind, randomized trial with a sham control group investigating the efficacy and safety of a computed tomography (CT)-guided, right-
Eligibility
Sex
ALL
Min Age
14 Years
Max Age
None
Locations
ImeldaziekenhuisBonheiden, Belgium
Algemeen Ziekenhuis Sint JanBruges, Belgium
Universitair Ziekenhuis GasthuisbergLeuven, Belgium
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT04755101